One was excluded for using a measure of "burnout" rather than depression.
Participants were not excluded for using more than one drug type during the study.
Thirteen controls were excluded for reporting use of disease-modifying antirheumatic drugs (DMARDs) typically used for the treatment of RA.
A total of 549 subjects completed the study, and data from 548 subjects were analyzed (one subject was excluded for statin use in the LF/HGI group).
Patients were excluded for prior use of thiazolidinediones or drugs known to affect lipid metabolism, energy metabolism, or body weight or drug abuse and smoking.
In particular, eight studies were excluded for not using multiple and/or overlapping case ascertainment methods.
Many studies were excluded for not using regression analysis (i.e., the study did not consider multiple determinants of adoption or fuel choice).
Patients were excluded for chronic laxative use, chronic use of fiber supplements, swallowing difficulties, known or suspected bowel obstruction, prior colon resection, allergy to psyllium or aspartame, or diabetes.
We also excluded for self-reported use of an antibiotic within one month of participation.
Patients were excluded for any previous use of chemotherapy for melanoma and any previous radiotherapy to target lesions.
